Regina Brown
2022
In 2022, Regina Brown earned a total compensation of $93.3K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 90% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $30,000 |
| Total | $93,340 |
Brown received $63.3K in option awards, accounting for 68% of the total pay in 2022.
Brown also received $30K in other compensation.
Rankings
In 2022, Regina Brown's compensation ranked 5,609th out of 5,753 executives tracked by ExecPay. In other words, Brown earned more than 2.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,609 out of 5,753 | 3rd |
Division Manufacturing | 3,063 out of 3,133 | 2nd |
Major group Chemicals And Allied Products | 1,391 out of 1,419 | 2nd |
Industry group Drugs | 1,298 out of 1,320 | 2nd |
Industry Pharmaceutical Preparations | 947 out of 966 | 2nd |
Source: SEC filing on November 4, 2024.
Brown's colleagues
We found six more compensation records of executives who worked with Regina Brown at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS